Health & wellbeing is a key theme within Urenco’s sustainability strategy. Safety is a priority at Urenco as well as the health and wellbeing of our employees. Urenco supports the health of people through our global operations and our social investment programme.
Safety is paramount at Urenco. We uphold the highest safety standards, driven by our journey towards safety excellence with the desire to ultimately achieve interdependent World Class status on the DuPont Bradley Curve at each of our locations, taking personal accountability for our safety and
the safety of others. We actively encourage colleagues to take responsibility for their personal safety both at work and at home.
In addition to our strong safety culture, our role in the nuclear power supply chain helps facilitate low carbon energy, which reduces pollution and positively impacts the health of people across the world.
An integral part of our global operations is our work with stable isotopes. We produce medical radioisotopes for three specific areas of the medical sector: diagnostics, therapy and pain relief. Each year, approximately two million patient treatments are performed using medical radioisotopes produced from Urenco’s enriched stable isotopes products.
Our Social Impact Partnership with the International Atomic Energy Agency (IAEA) includes working together on their Radioisotopes for Health project, which aims to advance treatments involving nuclear medicine through international collaboration. You can discover more about our work with the IAEA on our social impact page.